Guridi Jorge, Marigil Miguel, Becerra Victoria, Parras Olga
Servicio de Neurocirugía Clínica, Universidad de Navarra, Pamplona, España.
Servicio de Neurocirugía Clínica, Universidad de Navarra, Pamplona, España.
Neurocirugia (Astur). 2016 Nov-Dec;27(6):285-290. doi: 10.1016/j.neucir.2016.02.006. Epub 2016 May 6.
Subthalamic nucleus hyperactivity in Parkinson's disease may be a very early phenomenon. Its start is not well known, and it may occur during the pre-symptomatic disease stage. Glutamatergic hyperactivity may be neurotoxic over the substantia nigra compacta dopaminergic neurons. If this occurred, the excitatory neurotransmitter, glutamate, should affect the neurons that maintain a high turnover as a compensatory mechanism. Would a subthalamic nucleus lesion decrease this hyperactivity and thus be considered as a neuroprotective mechanism for dopaminergic neurons? The authors hypothesise about the possibility to perform surgery on a subthalamic nucleus lesion at a very early stage in order to avoid the neurotoxic glutamatergic effect over the dopaminergic neurons, and therefore be considered as a neuroprotective surgery able to alter the progress of the disease during early motor symptoms. In this regard, magnetic resonance-guided focused ultrasound techniques open a new window in the stereotactic armamentarium.